DM

Duncan Charles Miller

AL Astex Therapeutics Limited: 5 patents #50 of 199Top 30%
CL Cancer Research Technology Limited: 5 patents #85 of 493Top 20%
Pfizer: 3 patents #1,612 of 5,153Top 35%
Overall (All Time): #547,725 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12071429 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2024-08-27
11261171 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2022-03-01
10981898 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2021-04-20
10544132 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-28
10526311 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David CONS, Christopher Norbert Johnson +16 more 2020-01-07
10344017 Pyrrolcarboxamide derivatives for the inhibition of ERK5 Tristan REUILLON, Stephanie Myers, Lauren Molyneux, Celine Florence Cano, Ian Robert Hardcastle +4 more 2019-07-09
9079878 (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators Sharanjeet Kaur Bagal, Mark Ian Kemp, Yoshihisa Murata 2015-07-14
8927587 Chemical compounds Sharanjeet Kaur Bagal, Alan Daniel Brown, Mark Ian Kemp, Wolfgang Klute, Laia Malet Sanz +4 more 2015-01-06
7498329 Salt form of dopamine agonist Stuart P. Green, Olivier Lazzari, Fabrice Henri Salingue 2009-03-03